Literature DB >> 18081646

Review article: Helicobacter pylori eradication for the prevention of gastric cancer.

A C De Vries1, E J Kuipers.   

Abstract

BACKGROUND: Gastric cancer is the fourth most common cancer and second leading cause of cancer-related death worldwide. A clear association between Helicobacter pylori infection and gastric cancer was established years ago. H. pylori eradication may be an effective approach to decrease morbidity and mortality of gastric cancer. AIM: To discuss current evidence of H. pylori eradication for prevention of gastric cancer.
RESULTS: Recent studies have shown that the association between H. pylori and gastric cancer has probably been underestimated. This may have resulted from negative H. pylori status in subjects after loss of colonisation in the presence of atrophic gastritis and intestinal metaplasia, prior to development of gastric cancer. The recognition of the central role of H. pylori in carcinogenesis has increased expectations of gastric cancer prevention by H. pylori eradication. A primary preventive effect of eradication in subjects with H. pylori-induced gastritis has been demonstrated. However, a secondary preventive effect in patients with pre-malignant gastric lesions is still controversial, especially in patients with intestinal metaplasia and dysplasia.
CONCLUSIONS: At this moment, H. pylori eradication seems indicated at the earliest stage of gastric carcinogenesis. This treatment policy requires confirmation; results of ongoing randomised controlled trials are therefore eagerly awaited.

Entities:  

Mesh:

Year:  2007        PMID: 18081646     DOI: 10.1111/j.1365-2036.2007.03475.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  15 in total

1.  What are the therapeutic advances in gastroenterology? opinions from world experts.

Authors:  Timothy Cragin Wang; Gordon Mallarkey
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

2.  Ethnicity is a strong predictor for Helicobacter pylori infection in young women in a multi-ethnic European city.

Authors:  Wouter J den Hollander; I Lisanne Holster; Caroline M den Hoed; Frances van Deurzen; Anneke J van Vuuren; Vincent W Jaddoe; Albert Hofman; Guillermo I Perez Perez; Martin J Blaser; Henriëtte A Moll; Ernst J Kuipers
Journal:  J Gastroenterol Hepatol       Date:  2013-11       Impact factor: 4.029

Review 3.  Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions.

Authors:  Diogo Libânio; Mário Dinis-Ribeiro; Pedro Pimentel-Nunes
Journal:  World J Clin Oncol       Date:  2015-10-10

4.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

5.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

Review 6.  Gastric cancer: prevention, screening and early diagnosis.

Authors:  Victor Pasechnikov; Sergej Chukov; Evgeny Fedorov; Ilze Kikuste; Marcis Leja
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

7.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

Review 8.  Current Perspectives on Gastric Cancer.

Authors:  Juan M Marqués-Lespier; María González-Pons; Marcia Cruz-Correa
Journal:  Gastroenterol Clin North Am       Date:  2016-09       Impact factor: 3.806

9.  Is Gastric Xanthelasma an Alarming Endoscopic Marker for Advanced Atrophic Gastritis and Intestinal Metaplasia?

Authors:  Aydın Şeref Köksal; Nuretdin Suna; İsmail Hakkı Kalkan; Ahmet Tarık Eminler; Şükran Ziyşan Sakaoğulları; Nesrin Turhan; Fatih Saygılı; Ufuk Barış Kuzu; Erkin Öztaş; Erkan Parlak
Journal:  Dig Dis Sci       Date:  2016-06-01       Impact factor: 3.199

Review 10.  Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention.

Authors:  Iris Lansdorp-Vogelaar; Linda Sharp
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-09-27       Impact factor: 3.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.